Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Bayer blasts 'unscientific' rejection by Mexican regulator of GMO corn permit

Published 10/08/2021, 04:43 PM
Updated 10/08/2021, 05:11 PM
© Reuters. FILE PHOTO: The logo of Bayer AG is pictured at the facade of the historic headquarters of the German pharmaceutical and chemical maker in Leverkusen, Germany, April 27, 2020. REUTERS/Wolfgang Rattay/File Photo
MON
-
BAYRY
-

By David Alire Garcia

MEXICO CITY (Reuters) -Bayer is evaluating its legal options after Mexican health regulators for the first time rejected a GMO corn permit it was seeking, the German pharmaceutical and crop science giant said in a statement to Reuters on Friday, blasting the decision as "unscientific."

Reuters reported earlier in the day that regulator Cofepris rejected the corn permit for future import as the government of President Andres Manuel Lopez Obrador hardens its opposition to genetically modified crops.

"We are disappointed with the unscientific reasons that Cofepris used to deny the authorization," the statement said, identifying the rejected corn variety as using its proprietary HT3 x SmartStax Pro technology.

Bayer (OTC:BAYRY) stressed that the permit denial does not affect its current business, noting that last year the company stopped work on its HT3 hybrid corn varieties due to regulatory delays in the European Union in favor of a new HT4 line which the company expects to launch later this decade.

Bayer nonetheless criticized what it described as continuous regulatory delays with Cofepris as well as the possibility of additional permit denials that could have a "devastating impact" on Mexican supply chains.

The company said genetically modified crops including corn have undergone more safety tests than "any other crop in the history of agriculture" and have been judged safe for humans, animals and the environment.

The Cofepris press office did not respond to multiple requests for comment.

Lopez Obrador issued a controversial decree at the end of last year that outlined a three-year plan to ban the weed killer glyphosate and GMO corn for human consumption.

Industry associations have sharply criticized the plan and have sought unsuccessfully to persuade judges to strike it down, arguing that it risks a trade dispute with the United States. If the ban is interpreted to include animal feed or other industrial uses, they say it will ultimately hit consumers with higher food prices.

© Reuters. FILE PHOTO: The logo of Bayer AG is pictured at the facade of the historic headquarters of the German pharmaceutical and chemical maker in Leverkusen, Germany, April 27, 2020. REUTERS/Wolfgang Rattay/File Photo

The planned prohibition, however, is popular with environmentalists and health-food advocates who argue that spraying glyphosate on the GMO crops designed to tolerate them is indeed harmful.

Glyphosate was pioneered by the Roundup brand of weed killers from agrochemical company Monsanto (NYSE:MON), which was bought by Bayer as part of a $63 billion acquisition in 2018.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.